Gary Charles Robb - Mar 17, 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Gary Charles Robb
Stock symbol
CORT
Transactions as of
Mar 17, 2022
Transactions value $
-$308,428
Form type
4
Date filed
3/18/2022, 06:40 PM
Previous filing
Feb 15, 2023
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Sale -$185K -7.51K -8.95% $24.68 76.4K Mar 17, 2022 Direct F1, F2
transaction CORT Common Stock Sale -$123K -4.99K -6.53% $24.67 71.4K Mar 18, 2022 Direct F1
holding CORT Common Stock 5.81K Mar 17, 2022 Custodial account for child F3
holding CORT Common Stock 5.81K Mar 17, 2022 Custodial account for child F3
holding CORT Common Stock 5.81K Mar 17, 2022 Custodial account for child F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.67 to $24.70. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.